Medical Services Expenditures per Capita by Disease: Infectious and Parasitic Diseases, MEPS Account Basis (INFAPSPCMEPS) | FRED | St. Louis Fed
- Rows
- 22
- Columns
- 2
- Data range
- 2000-01-01 to 2021-01-01
Graph and download economic data for Medical Services Expenditures per Capita by Disease: Infectious and Parasitic Diseases, MEPS Account Basis (INFAPSPCMEPS) from 2000 to 2021 about infection, disease, healthcare, medical, health, expenditures, per capita, services, and USA.
AI analysis
Dataset Analysis: Medical Services Expenditures per Capita — Infectious and Parasitic Diseases (MEPS)
1. Dataset Overview and Value
This dataset, sourced from FRED (Federal Reserve Bank of St. Louis) at fredgraph.csv?id=INFAPSPCMEPS, tracks annual per-capita medical expenditures for infectious and parasitic diseases in the U.S., drawing on the Medical Expenditure Panel Survey (MEPS) account basis. The FRED/St. Louis Fed pedigree lends strong credibility — this is a well-governed macroeconomic data warehouse that aggregates federal survey data (MEPS is run by AHRQ) rather than a raw primary source. The series spans 2000–2021, giving 22 annual observations. This long-run annual granularity makes it well-suited for correlation studies against other national-level economic or health indicators (GDP, CPI-medical, disease incidence rates, insurance coverage rates) rather than for high-frequency or granular geographic analysis, since it's a single national aggregate series with no state/demographic breakdowns.
2. Data Quality
Data quality appears excellent on the surface: zero null cells across both columns, and 22 distinct values in both the date key and the value column (implying no duplicate observation dates). However, the duplicate-row check is flagged as pending ("Phase D — recomputed against Parquet"), so true deduplication hasn't been formally verified yet — this should be confirmed before treating the row count as final. Also, the "Sample Data" section shows zero preview rows, meaning no actual record-level values have been inspected yet; all conclusions here rest on aggregate statistics rather than eyeballed data, which is a gap worth closing before deeper analysis.
3. Key Column Distributions
The INFAPSPCMEPS value column shows a mean of $132.67 versus a median of $108.04 — the mean sitting well above the median signals right-skew, confirmed by a skewness coefficient of 2.24 (strongly positive/right-skewed). This is corroborated by the wide gap between Q3 ($163.66) and the max ($402.75), compared to a much tighter Q1–median range ($81.61–$108.04). One outlier is flagged, almost certainly the maximum value ($402.75), likely representing a late-year spike (plausibly pandemic-era 2020/2021 data, given infectious disease spending would spike sharply during COVID-19). This single outlier meaningfully distorts the mean and should be considered for winsorizing or log-transformation before regression-based correlation work, or alternatively treated as a genuine structural break worth its own analysis.
4. Recommended Join Keys
observationdate is the clear and only viable join key — it's a clean annual date field (Jan 1 of each year, 2000–2021) with zero nulls and full distinctness. For cross-dataset correlation, this should be joined against other FRED series or external datasets using year-truncated date matching (since granularity is annual, not monthly/quarterly). Analysts should ensure any paired dataset is either already annual or is aggregated (mean/sum) to annual frequency before joining, to avoid many-to-one join artifacts.
5. Suggested Complementary Datasets
Strong pairing candidates include: (a) other MEPS-basis disease expenditure series (e.g., cardiovascular, cancer, respiratory disease per-capita spending) to compare relative cost growth across disease categories; (b) CPI for Medical Care Services (CPIMEDSL on FRED) to distinguish real spending growth from inflation-driven increases; (b) CDC/NNDSS infectious disease incidence and mortality rates, to test whether spending tracks disease burden or lags it; (c) health insurance coverage rates (e.g., Census/FRED uninsured rate series) as a potential driver of expenditure patterns; and (d) the likely COVID-19 spike suggests pairing with pandemic-era indicators (case counts, stringency indices) to explicitly model the 2020–2021 discontinuity rather than let it skew a naive linear correlation.
Columns
- observation_date (date)
- INFAPSPCMEPS (decimal)